Russ Olsen
Chief Executive Officer
Russ has over 35 years of experience in executive management, sales, and marketing. He gained much of his executive management experience while holding senior positions in marketing, business development, and sales for Fortune 500 companies, including Bristol-Myers Squibb and Smith & Nephew. Russ has served as Global President for Derma Sciences, Chief Executive Officer of BioD, LLC, President of North America for Straumann AG, Chief Executive Officer and President of Keystone Dental, and Chief Executive Officer of CloudDDS.
George White
Chief Operating Officer
George oversees ongoing operations and procedures while developing the architecture for Triad’s commercialization, growth strategies, and strategic business initiatives. Prior to joining the Triad team in 2017, George garnered over 25 years of experience in the investment industry as a successful hedge fund manager, co-founding WellSpring Capital Management where he served as partner. George earned his bachelor’s degree in economics from the University of Mississippi and his MBA from Columbia University.
Donna Best
Chief Legal Officer
Donna has over 20 years of experience in the biotechnology and tissue banking industries. A registered patent attorney, she began her legal career as an associate at Sutherland Asbill & Brennan LLP (now Eversheds Sutherland LLP), and most recently was the General Counsel of BioD, LLC where she was a key member of the executive management team. Donna has held various positions of leadership and management for biotech companies such as the Cell Therapy Research Foundation, Mid-South Tissue Bank, and Mid-South Transplant Foundation.
Laine Dyess
Executive Vice President of Sales
Laine has over 20 years of experience in leadership and medical sales. His leadership foundation began in the United States Air Force and continued during his career with Pfizer Pharmaceuticals, Shire Regenerative Medicine, and most recently with Osiris Therapeutics. Laine has a proven history of commercializing high performing sales teams and fostering a highly collaborative internal culture.
Jon Hargis
Executive Vice President of Research & Development
Jon has over 10 years of experience in processing. He began his career processing corneas, sclera, pericardium, bone, skin and adipose tissue for Tissue Banks International. Jon has held management positions in processing, production, quality and operations with the National Eye Bank Center and BioD, LLC.
Gary Robertson
Vice President of Finance
Gary has over 25 years of experience in finance and accounting management. He has served as the Senior Manager of Assurance for KPMG, a senior leader in the development of Pfizer’s North American Financial Shared Services Group, and the Director of Finance over Smith & Nephew’s Clinical Therapies/Biologics division. Gary was also a leading contributor in the subsequent spin-off of that division – Bioventus – of which he became the Commercial Controller of US Operations.